Recently added

Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas

Chong, Elise A.; Penuel, Elicia; Napier, Ellen; Lundberg, Rachel K.; Shadman, Mazyar; Budde, Lihua; Bosch, Francesc (American Society of Hematology, 2025-02-12)

Multimodal data integration in early-stage breast cancer

Llinas-Bertran, Arnau; Butjosa-Espín, Maria; Barberi, Vittoria; Seoane Fernández, Jose Antonio (Elsevier, 2025-04)

Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors

Alouani, Emily; Sinicrope, Frank; Decraecker, Marie; Ros Codoñer, Javier; taieb, julien; Ambrosini, Margherita; Lonardi, Sara (BMJ, 2025-01)

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study

Bhatia, Shailender; Topalian, Suzanne; Sharfman, William; Meyer, Tim; Steven, Neil; Lao, Christopher D.; Fariñas-Madrid, Lorena (American Society of Clinical Oncology, 2025-03-20)

MIA40 circumvents the folding constraints imposed by TRIAP1 function

Pujols Pujol, Jordi; Fornt-Suñé, Marc; Gil-Garcia, Marcos; Bartolomé-Nafría, Andrea; Cerofolini, Linda; Canals, Francesc (Elsevier, 2025-03)

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas

Multimodal data integration in early-stage breast cancer

Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study

MIA40 circumvents the folding constraints imposed by TRIAP1 function

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas ﻿

Multimodal data integration in early-stage breast cancer ﻿

Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors ﻿

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study ﻿

MIA40 circumvents the folding constraints imposed by TRIAP1 function ﻿

Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas

Multimodal data integration in early-stage breast cancer

Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study

MIA40 circumvents the folding constraints imposed by TRIAP1 function